Mylan Inc (NASDAQ:MYL)

CAPS Rating: 4 out of 5

The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients.

Recs

0
Player Avatar Zee (< 20) Submitted: 12/28/2013 8:05:01 PM : Outperform Start Price: $42.77 MYL Score: +10.42

strength in the emerging biotech market of biosimilars

Featured Broker Partners


Advertisement